REG - Surgical Innovations - Year-end trading update <Origin Href="QuoteRef">SUNU.L</Origin>

Surgical InnovationsAnnouncement

11/01/2018 07:00

RNS Number : 5348B
Surgical Innovations Group PLC
11 January 2018
Surgical Innovations Group plc
("Group" or the "Company")
Year-end Trading Update
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, is pleased to provide an update on trading for the year ended 31 December 2017. 
Group revenue for the year exceeded 8.7m, representing growth of approximately 44% over 2016. Within this, organic growth in the existing business was approximately 10%. The integration of Elemental Healthcare Limited, acquired in August 2017, continues in line with plan and following the acquisition, the reaction of both distributors and suppliers to both businesses has been very positive. 
The combined gross margins were within target range and the increasing levels of profitability are in line with board and market expectations. 
Audited results for the year ended 31 December 2017 will be released in mid-March 2018.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.
For further information please contact:
Surgical Innovations Group plc
www.sigroupplc.com
Nigel Rogers, Executive Chairman
Tel: 0113 230 7597
Melanie Ross, COO & CFO
WH Ireland Limited (NOMAD & Broker)
Tel: 0113 394 6600
Tim Feather
Alex Bond
Walbrook PR (Financial PR & Investor Relations)
Tel: 020 7933 8780 or si@walbrookpr.com
Paul McManus
Mob: 07980 541 893
Lianne Cawthorne
 Mob: 07584 391 303

This information is provided by RNS
The company news service from the London Stock Exchange
  END
TSTSFWFMSFASEIF